Skip to main content

Advertisement

Table 1 Patient Demographics

From: Age-related sarcoma patient experience: results from a national survey in England

  Bone (n = 140) Soft Tissue (n = 418)
  TOTAL (n = 558) BONE (n = 140) SOFT TISSUE (n = 418) AYA (n = 23) Middle-age (n = 78) Elderly (n = 39) AYA (n = 23) Middle-age (n = 207 Elderly (n = 188)
Age
 Mean(SD) 64.1 (15.5) 57 (18.0) 66.2 (14.0) 26.4 (6.9) 57.4 (8.7) 77 (5.0) 31.1 (5.6) 59.7 (8.3) 77.6 (5.5)
Gender
 Male 274 (49.1%) 78 (55.7%) 196 (46.9%) 15 (65.2%) 40 (51.3%) 23 (59.0%) 8 (34.8%) 91 (44.0%) 97 (51.6%)
 Female 284 (50.9%) 62 (44.3%) 222 (53.1%) 8 (34.8%) 38 (48.7%) 16 (41.0%) 15 (65.2%) 116 (56.0%) 91 (48.4%)
Site of Disease
 Head/neck 70 (12.5% 44 (31.4%) 26 (6.2%) 1 (4.3%) 24 (30.8%) 19 (48.7%) 2 (8.7%) 9 (4.3%) 15 (8.0%)
 Thorax 32 (5.7%) 6 (4.3%) 26 (6.2%) 1 (4.3%) 3 (3.8%) 2 (5.1%) 1 (4.3%) 14 (6.8%) 11 (5.9%)
 Abdomen 129 (23.1%) n/a 129 (30.9%) n/a n/a n/a 6 (26.1%) 63 (30.4%) 60 (31.9%)
 Pelvis 46 (8.2%) 21 (15.0%) 25 (6.0%) 5 (21.7%) 11 (14.1%) 5 (12.8%) 1 (4.3%) 15 (7.2%) 9 (4.8%)
 Upper limb 68 (12.2%) 15 (10.7%) 53 (12.7%) 3 (13.0%) 8 (10.3%) 4 (10.3%) 3 (13.0%) 22 (10.6%) 28 (14.9%)
 Lower limb 177 (31.7%) 40 (28.6%) 137 (32.8%) 11 (47.8%) 21 (26.9%) 8 (20.5%) 9 (39.1%) 70 (33.8%) 58 (30.9%)
 Vertebral column 6 (1.1%) 6 (4.3%) n/a 1 (4.3%) 5 (6.4%) 0 (0.0%) n/a n/a n/a
 Skin 9 (1.6%) n/a 9 (2.2%) n/a n/a n/a 1 (4.3%) 6 (2.9%) 2 (1.1%)
 Unspecified 21 (3.8%) 8 (5.7%) 13 (3.1%) 1 (4.3%) 6 (7.7%) 1 (2.6%) 0 (0.0%) 8 (3.9%)  
Treatments Received
 Surgery 502 (90.0%) 129 (92.1%) 374 (89.5%) 18 (78.3%) 75 (96.2%) 36 (92.3%) 19 (82.6%) 186 (90.0%) 169 (90%)
 Radiotherapy 246 (44.1%) 58 (41.4%) 188 (45.0%) 13 (56.5%) 32 (41.0%) 13 (33.3%) 16 (69.6%) 95 (45.9%) 77 (41.0%)
 Chemotherapy 201 (36.0%) 55 (39.3%) 146 (34.9%) 20 (87.0%) 33 (42.3%) 2 (5.1%) 17 (73.9%) 81 (39.1%) 48 (25.5%)
 Other 27 (4.8%) 10 (7.1%) 17 (4.1%) 2 (8.7%) 5 (6.4%) 3 (7.7%) 0 (0.0%) 11 (5.3%) 6 (3.2%)
Follow-up
  < 3 monthly 89 (17.4%) 37 (28.2%) 52 (13.7%) 7 (30.4%) 17 (23.9%) 13 (35.1%) 3 (13.4%) 30 (15.8%) 19 (11.2%)
 3 monthly 232 (45.4%) 49 (37.4%) 183 (48.2%) 9 (39.1%) 32 (45.1%) 8 (21.6%) 12 (57.1%) 94 (49.5%) 77 (45.6%)
  > 3–6 monthly 128 (25.0%) 34 (26.0%) 94 (24.7%) 5 (21.7%) 18 (25.4%) 11 (29.7%) 3 (14.3%) 41 (21.6%) 50 (29.6%)
 Annual 23 (4.5%) 6 (4.6%) 17 (4.5%) 2 (8.7%) 1 (1.4%) 3 (0.0%) 0 (0.0%) 11 (5.8%) 6 (3.6%)
 Never 12 (2.3%) 1 (0.8%) 11 (2.9%) 0 (0%) 1 (1.4%) 0 (0%) 1 (4.8%) 3 (1.6%) 7 (4.1%)
 Variable 27 (5.3%) 4 (3.1%) 23 (6.1%) 0 (0%) 2 (2.8%) 2 (5.4%) 2 (9.5%) 11 (5.8%) 10 (5.9%)